October 17, 2021 “In the biotech industry, the one thing that is missing more than anything else is funding” View Article
September 27, 2021 Chemomab Therapeutics Announces Collaboration with Leeds University to Further Elucidate the Role of CCL24 in Vascular Damage Associated with Systemic Sclerosis View Article
September 23, 2021 Groundbreaking Israeli Diagnostic Test Gets FDA Approval. The Next Challenge: Selling It to America View Article
September 21, 2021 Dr. Noam Emanuel on Tackling Surgical Site Infections, a $10 Billion Healthcare System Problem View Article
September 13, 2021 PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer View Article
September 2, 2021 Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer View Article
August 5, 2021 MeMed Named a Finalist for AACC’s Disruptive Technology Award for MeMed COVID-19 Severity™ Test View Article
